PATENT CLAIM ANALYSIS

Application Number: 16199905
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "114000"]

Abstract:
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.

Claim (Index 9):
A method of ameliorating, preventing or limiting a negative chronotrophic side effect associated with a treatment of an autoimmune disease using an S1P modulator or agonist, e.g. compound A, B, or a salt or prodrug thereof, the method comprising administering the S1P receptor modulator or agonist at a daily dosage which is lower than the standard daily dosage during an initial treatment period and raising the daily dosage, optionally stepwise, up to the standard daily dosage.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 98.0
- Lexical Diversity: 1.20833
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12655049', '14732013', '14322722', '15986992', '15534929']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7539545223149071
- 35 USC 102 Novelty (BERT): 0.5504463021932838
- Combined Prediction Score: 0.7336037003027448
- Mean Citation Score: 288.4315200000001
- Max Citation Score: 407.60342
- Similarity Product: 373.9277498707581

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test